Skip to Content

Smith & Nephew PLC ADR SNN Stock Quote

| Rating as of


Last close prices updated as of Jun 02, 2023, 4:49 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 29.93
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Mid Blend
  • Day Range 29.97  –  30.41
  • Year Range 21.78  –  33.09
  • Market Cap 13.2055 Bil
  • Volume / Avg 856,057.0 /  965,898.2
  • Price / Sales 2.51
  • Price / Book 2.49
  • Forward Div Yield 2.51%
  • Trailing Div Yield 2.48%

Morningstar‘s Stock Analysis SNN

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Smith & Nephew Aims to Leverage Its Footprint in Ambulatory Surgical Centers; No Change to Our FVE

Debbie S. Wang Senior Equity Analyst

Business Strategy and Outlook

| Debbie Wang |

Impressive innovation has allowed Smith & Nephew to carve out a slice of the orthopedic, sports medicine, and wound care markets. Though the company is substantially smaller than the dominant orthopedic competitors, it has punched above its weight in terms of introducing meaningful innovation with its pioneering hip resurfacing implant and knee replacements with Verilast technology, which it contends can last for 30 years. These are significant improvements that exceed the evolutionary innovation typically seen in orthopedics.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SNN

Company Profile SNN

Business Description

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Hatters Lane, Building 5, Croxley Park
Watford, Hertfordshire, WD18 8YE, GBR
Industry Medical Devices
Employees 11,000

Related Articles SNN

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of SNN’s competitive advantage.

Smith & Nephew PLC ADR


Stryker Corp


Zimmer Biomet Holdings Inc

+$0.31 (1.04%) −$0.27 (0.10%) +$2.45 (1.92%)
Market Cap
13.21 Bil105.64 Bil27.07 Bil
Medical Devices Medical Devices Medical Devices

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Smith & Nephew PLC ADR Stock

Yes. SNN has a forward dividend yield of 2.51%. See SNN’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SNN’s market cap is 13.21 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SNN’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SNN’s price/sales is 2.51.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

SNN’s price/forward earnings is 58.69.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

SNN’s price/book is 2.49.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See SNN’s valuation ratios compared to the Market Index.

SNN’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SNN’s historical performance against its industry peers and the overall market.